AMTX

Aemetis, Inc. (AMTX) - Form 10-Q Summary

Business Context and Reporting Period

This summary covers the quarterly period ended June 30, 2026. Aemetis, Inc. is a renewable natural gas and biofuels company operating three primary segments: California Ethanol (Keyes Plant), California Dairy Renewable Natural Gas (RNG), and India Biodiesel (Kakinada Plant). The company focuses on producing low-carbon fuels and environmental credits (LCFS, RINs, Section 45Z PTCs).

Key Financial Metrics

Note: Data presented in thousands in source; converted to millions for readability. Q2 2026 results include Section 45Z Production Tax Credits (PTCs) recognized as revenue, whereas 2025 results did not include PTC income in the same period.

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 20.0% in Q2 2026 compared to Q2 2025. This was driven by a 41.8% increase in California Ethanol revenue and a 140.1% increase in RNG revenue, partially offset by a 78.9% decline in India Biodiesel revenue due to a lack of government tender contracts in Q2 2026.
• Profitability Turnaround: The company moved from a gross loss of $3.4 million in Q2 2025 to a gross profit of $13.5 million in Q2 2026. This shift is primarily attributed to the recognition of $8.6 million in Section 45Z PTC income ($6.5M Ethanol, $2.1M RNG), improved ethanol volumes, and reduced corn costs.
• Debt Expansion: Total debt increased to $415.9 million as of June 30, 2026, from $381.8 million at year-end 2025. This increase is largely due to accrued interest ($26.7 million) and new borrowings for construction and working capital.
• India Segment Volatility: India Biodiesel revenue dropped significantly in Q2 2026 ($2.5M) compared to Q2 2025 ($11.9M) due to the absence of Palm Fatty Acid Distillate (PFAD) sales and delayed Oil Marketing Company (OMC) contracts.

Guidance, Outlook, and Risks

• Going Concern Warning: Management explicitly states that "substantial doubt exists about our ability to continue as a going concern over the next twelve months" due to high debt levels, reliance on a senior secured lender (Third Eye Capital), and expected near-term cash flow shortfalls.
• Liquidity Strategy: The company plans to improve liquidity by monetizing Section 45Z PTCs, optimizing operations at the Keyes Plant (including the upcoming Mechanical Vapor Recompression system), expanding RNG digesters, and continuing at-the-market equity sales.
• Debt Covenants: The company obtained waivers for violations of debt-to-plant value and capital expenditure covenants as of June 30, 2026. A significant portion of debt ($269.6 million) is due on demand.
• Regulatory Outlook: Recent federal legislation ("One Big Beautiful Bill") enacted in July 2025 extended Section 45Z credit terms to five years and is expected to increase credit values for RNG production.

Investor Verification Checklist

• Debt Maturity & Refinancing: Verify the status of the $269.6 million in Third Eye Capital debt due on demand and the company's ability to secure extensions or refinancing.
• PTC Monetization: Confirm the actual cash proceeds received from the sale of Section 45Z tax credits versus the accrued revenue recognized on the balance sheet.
• India OMC Contracts: Monitor the status of government tender allocations for the India Biodiesel segment to assess revenue recovery in subsequent quarters.
• Capital Expenditures: Review the progress and funding status of the Mechanical Vapor Recompression (MVR) system at the Keyes Plant and new RNG digesters, which are critical for margin improvement.
• Equity Dilution: Track the volume of shares sold under the at-the-market program, which generated $13.7 million in proceeds YTD 2026, to assess dilution impact.